bso glutathione inhibitor L-Buthionine-(S,R)-sulfoximine (L-Buthionine sulfoximine) | G-glutamylcysteine Synthetase sulfoximine is suitable for use to Sigma-Aldrich ᴅʟ-Buthionine-sulfoximine, CAS 5072-26-4, ≥99.0%
Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum A novel small molecule that induces cytotoxicity in lung cancer cells inhibits disulfide reductases GSR and TXNRD1 bioRxiv Depletion of cellular GSH by treatment with l Download Scientific Diagram PDF] Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Semantic Scholar
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




